Literature DB >> 32818937

Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy.

João Moreira-Pinto1, Inês Leão2, Carolina Palmela3, Francisco Branco4, João Godinho4, Pedro Simões4, Luisa Leal-Costa4, Fabio Lopes4, Ana Faria4, Mafalda Casa-Nova4, Ana Escária5, Filipa Costa6, Isabel Galvão7, José Teixeira4, José Luís Passos-Coelho4.   

Abstract

INTRODUCTION: Febrile neutropenia (FN) is a potentially life-threatening complication of systemic chemotherapy (CT) that often requires hospital admission. Delay in diagnosis and treatment are associated with higher morbidity and mortality.
OBJECTIVE: We aimed to determine the factors that influence FN episodes outcomes in the emergency room (ER).
METHODS: This was a retrospective study of all FN episodes (with a collected blood culture [BC]) that occurred between 2012 and 2016 at our institution. FN was defined as a temperature ≥38°C and an absolute neutrophil count (ANC) <1,000/μL, expected to decrease to <500/μL in the following week.
RESULTS: Between 2012 and 2016, there were 173 FN episodes in 153/1,947 patients treated with intravenous CT. Most of these episodes (n = 121, 70%) were diagnosed in the ER, 29 in the outpatient clinic, and 23 as inpatients. In the ER, the median time was 36 min from hospital nurse triage to medical observation, and 52 min from medical observation to complete blood count specimen collection. There was a positive BC in 33 FN episodes, 72% with Gram-negative bacteria. A total of 160 FN episodes led to hospital admission and 13 were treated as outpatients. Mortality associated with the FN episode was 15% and an ANC <100/μL was predictive of increased mortality.
CONCLUSION: This study confirms that FN is a serious and common complication of IV CT which must be diagnosed and treated promptly. Profound neutropenia was the only predictive factor of mortality.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Chemotherapy; Complication management; Disease management; Febrile neutropenia; Supportive care

Mesh:

Substances:

Year:  2020        PMID: 32818937     DOI: 10.1159/000506109

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  2 in total

1.  Burden, risk factors, and management of neutropenic fever among solid cancer patients in Ethiopia.

Authors:  Samuel Agegnew Wondm; Ephrem Mebratu Dagnew; Sumeya Tadesse Abegaz; Mekdes Kiflu; Bekalu Kebede
Journal:  SAGE Open Med       Date:  2022-05-19

2.  Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study.

Authors:  Emma Balch Steen-Olsen; Helle Pappot; Allan Green; Henning Langberg; Cecilie Holländer-Mieritz
Journal:  JMIR Res Protoc       Date:  2022-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.